Drug Profile
Research programme: recombinant tetravalent dengue vaccine - BioNet Asia
Alternative Names: Dengue vaccine - BioNet-AsiaLatest Information Update: 28 Nov 2023
Price :
$50
*
At a glance
- Originator BioNet-Asia
- Class Dengue vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dengue
Most Recent Events
- 28 Nov 2023 No recent reports of development identified for preclinical development in Dengue(Prevention) in Thailand (Parenteral)
- 23 Nov 2021 Preclinical trials ongoing in Dengue (Prevention) in Thailand (Parental) (BioNet-Asia pipeline, November 2021)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Dengue(Prevention) in Thailand (Parenteral)